Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Title:
PLoS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
19
October
2016
Publication date Collection: 2016
Volume: 11
Issue: 10
Electronic Location Identifier: e0164109
Affiliations
[1
]Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark
[2
]Department of Renal Medicine. Aarhus University Hospital, Aarhus, Denmark
[3
]Department of Urology, Aarhus University Hospital, Aarhus, Denmark
[4
]Zealand Pharma A/S, Glostrup, Denmark
[5
]Department of Pathology, Aarhus University Hospital, Aarhus, Denmark
[6
]Comparative Medicines Lab, Aarhus University, Aarhus, Denmark
[7
]Department of Biomedicine, Aarhus University, Aarhus, Denmark
University of Sao Paulo Medical School, BRAZIL
Author notes
Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following
competing interests: Rie Schultz Hansen is an employee of Zealand Pharma. This does
not alter our adherence to PLOS ONE policies on sharing data and materials.
-
Conceptualization: CA AKK RSH RN UM MP BJ HB.
-
Formal analysis: CA AKK HB.
-
Funding acquisition: BJ RSH.
-
Investigation: CA UM AKK.
-
Methodology: CA AKK RSH RN SPK UM MP BJ HB.
-
Project administration: CA.
-
-
Validation: RSH RN BJ HB.
-
Writing – original draft: CA.
-
Writing – review & editing: CA AKK RSH RN UM MP BJ HB.
Author information
Article
Publisher ID:
PONE-D-16-15862
DOI: 10.1371/journal.pone.0164109
PMC ID: 5070773
PubMed ID: 27760220
SO-VID: 81dc8134-bf67-4e74-8d14-cb9d9b738c2e
Copyright © © 2016 Amdisen et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
Funded by: Zealand Pharma A/S
Award Recipient
:
Bente Jespersen
Zealand Pharma A/S, Glostrup Denmark funded the study. They participated in the study
design (dose of Danegaptide) and preparation of the manuscript. They had no role in
the data collection, analysis or decision to publish.
Subject:
Research Article
Subject:
Biology and Life Sciences
Subject:
Anatomy
Subject:
Renal System
Subject:
Kidneys
Subject:
Medicine and Health Sciences
Subject:
Anatomy
Subject:
Renal System
Subject:
Kidneys
Subject:
Biology and Life Sciences
Subject:
Physiology
Subject:
Renal Physiology
Subject:
Glomerular Filtration Rate
Subject:
Medicine and Health Sciences
Subject:
Physiology
Subject:
Renal Physiology
Subject:
Glomerular Filtration Rate
Subject:
Medicine and Health Sciences
Subject:
Critical Care and Emergency Medicine
Subject:
Reperfusion
Subject:
Medicine and Health Sciences
Subject:
Vascular Medicine
Subject:
Ischemia
Subject:
Renal Ischemia
Subject:
Medicine and Health Sciences
Subject:
Vascular Medicine
Subject:
Ischemia
Subject:
Biology and Life Sciences
Subject:
Agriculture
Subject:
Livestock
Subject:
Swine
Subject:
Biology and Life Sciences
Subject:
Organisms
Subject:
Animals
Subject:
Vertebrates
Subject:
Amniotes
Subject:
Mammals
Subject:
Swine
Subject:
Biology and Life Sciences
Subject:
Anatomy
Subject:
Cardiovascular Anatomy
Subject:
Blood Vessels
Subject:
Arteries
Subject:
Renal Arteries
Subject:
Medicine and Health Sciences
Subject:
Anatomy
Subject:
Cardiovascular Anatomy
Subject:
Blood Vessels
Subject:
Arteries
Subject:
Renal Arteries
Subject:
Biology and Life Sciences
Subject:
Anatomy
Subject:
Body Fluids
Subject:
Blood
Subject:
Blood Flow
Subject:
Medicine and Health Sciences
Subject:
Anatomy
Subject:
Body Fluids
Subject:
Blood
Subject:
Blood Flow
Subject:
Biology and Life Sciences
Subject:
Physiology
Subject:
Body Fluids
Subject:
Blood
Subject:
Blood Flow
Subject:
Medicine and Health Sciences
Subject:
Physiology
Subject:
Body Fluids
Subject:
Blood
Subject:
Blood Flow
Subject:
Medicine and Health Sciences
Subject:
Hematology
Subject:
Blood
Subject:
Blood Flow